The UK market for penicillins and streptomycins in dosage form is projected to decrease from $726.33 million in 2024 to $688.17 million in 2028. The forecast reflects a consistent year-on-year decline, with a 1.35% decrease from 2024 to 2025, a 1.35% decline from 2025 to 2026, a 1.34% drop from 2026 to 2027, and a 1.32% downturn expected from 2027 to 2028. A five-year CAGR indicates an average annual reduction of 1.35% up to 2028 compared to the market size in 2023.
Future trends to watch for include advancements in antibiotic alternative treatments, regulatory changes affecting antibiotic prescriptions, and the impact of antimicrobial resistance which could alter consumption patterns and influence market dynamics significantly in the coming years.
